Sign inGet started

Brandt Peter C.

Insider CIK 1434099 · EPOC Director · AUXL Director · RNN Director · INAB Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
INAB IN8BIO, INC. A Award deriv2026-05-092026-05-1222,000— $022,000SEC↗
INAB IN8BIO, INC. A Award2025-12-222025-12-2372,464$1.38 $100.0K95,181SEC↗
INAB IN8BIO, INC. A Award deriv2025-05-082025-05-1263,150— $063,150SEC↗
INAB IN8BIO, INC. M Exercise deriv2025-04-302025-05-0781,967— $00SEC↗
INAB IN8BIO, INC. M Exercise deriv2025-04-302025-05-0781,967— $00SEC↗
INAB IN8BIO, INC. M Exercise2025-04-302025-05-0781,967$0.18 $14.8K681,538SEC↗
INAB IN8BIO, INC. M Exercise2025-04-302025-05-0781,967$0.18 $14.8K599,571SEC↗
INAB IN8BIO, INC. D To issuer deriv2025-04-272025-05-0781,967— $00SEC↗
INAB IN8BIO, INC. A Award deriv2025-04-272025-05-0781,967— $081,967SEC↗
INAB IN8BIO, INC. D To issuer deriv2025-04-272025-05-0781,967— $00SEC↗
INAB IN8BIO, INC. A Award deriv2025-04-272025-05-0781,967— $081,967SEC↗
INAB IN8BIO, INC. A Award deriv2024-12-192024-12-2349,490— $049,490SEC↗
INAB IN8BIO, INC. A Award deriv2024-10-042024-10-0881,967— $081,967SEC↗
INAB IN8BIO, INC. D To issuer deriv2024-10-042024-10-0881,967— $00SEC↗
INAB IN8BIO, INC. A Award deriv2024-10-042024-10-08253,164— $0253,164SEC↗
INAB IN8BIO, INC. A Award2024-10-042024-10-08253,164— $0517,604SEC↗
INAB IN8BIO, INC. A Award deriv2024-06-122024-06-1433,650— $033,650SEC↗
INAB IN8BIO, INC. A Award deriv2023-12-132023-12-1581,967— $081,967SEC↗
INAB IN8BIO, INC. A Award deriv2023-12-132023-12-1581,967— $081,967SEC↗
INAB IN8BIO, INC. A Award2023-12-132023-12-1581,967— $0264,440SEC↗
INAB IN8BIO, INC. A Award deriv2023-06-152023-06-1685,000— $085,000SEC↗
INAB IN8BIO, INC. P Buy2022-08-162022-08-18105,263$1.90 $200.0K182,473SEC↗
INAB IN8BIO, INC. A Award deriv2022-06-012022-09-2313,500— $013,500SEC↗
INAB IN8BIO, INC. A Award deriv2022-06-012022-06-1410,500— $010,500SEC↗
INAB IN8BIO, INC. A Award deriv2021-07-292021-08-0210,500— $010,500SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2019-06-062019-06-073,537— $03,537SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2018-06-282018-06-2939,742— $039,742SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2017-04-112017-04-12110,000— $0110,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2016-06-092016-06-10225,000— $0225,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2015-09-162015-09-1890,000— $090,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other deriv2015-01-292015-01-305,000$36.53 $182.7K0SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other deriv2015-01-292015-01-305,000$36.53 $182.7K0SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other deriv2015-01-292015-01-3015,000$36.53 $548.0K0SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other deriv2015-01-292015-01-3015,000$36.53 $548.0K0SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other deriv2015-01-292015-01-305,000$36.53 $182.7K0SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other2015-01-292015-01-3020,000— $05,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I J Other2015-01-292015-01-305,000$36.53 $182.7K0SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2014-06-092014-06-1160,000— $060,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I A Award deriv2014-05-212014-05-225,000— $05,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I A Award2014-05-212014-05-225,000— $025,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2013-06-112013-06-1360,000— $060,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I A Award deriv2013-05-012013-05-035,000— $05,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I A Award2013-05-012013-05-035,000— $020,000SEC↗
EPOC EPOCRATES INC D To issuer deriv2013-03-122013-03-1311,790— $00SEC↗
EPOC EPOCRATES INC D To issuer deriv2013-03-122013-03-13100,000— $00SEC↗
EPOC EPOCRATES INC D To issuer deriv2013-03-122013-03-1319,650— $00SEC↗
EPOC EPOCRATES INC D To issuer deriv2013-03-122013-03-1311,790— $00SEC↗
EPOC EPOCRATES INC D To issuer2013-03-122013-03-1338,729— $00SEC↗
EPOC EPOCRATES INC A Award deriv2012-08-132012-08-1411,790— $011,790SEC↗
AUXL AUXILIUM PHARMACEUTICALS I A Award deriv2012-06-212012-06-225,000— $05,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I A Award2012-06-212012-06-225,000— $015,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2012-06-182012-06-2020,000— $020,000SEC↗
AUXL AUXILIUM PHARMACEUTICALS I P Buy2012-02-282012-03-01300$20.09 $6.0K300SEC↗
AUXL AUXILIUM PHARMACEUTICALS I P Buy2012-02-282012-03-019,700$20.10 $195.0K10,000SEC↗